相关实验视频
Updated: Jul 17, 2025
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.0K
肠道微生物群和肝硬化之间的交叉对话:并发症和治疗目标
Yuan Yao1,2, Yunfeng Shen3
1Department of Metabolism and Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Open life sciences
|September 6, 2023
概括
在全球范围内,非酒精性脂肪性肝病 (NAFLD) 正在增加. 受饮食影响的肠道微生物组失调,在NAFLD发展中起着关键作用,并呈现出潜在的治疗点.
科学领域:
- 胃肠病学和肝病学
- 微生物学 微生物学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 肝硬化,一种普遍的慢性肝病,影响全球24%,与肥胖和胰岛素抵抗等代谢综合征成分密切相关.
- 胃肠道拥有数万亿种微生物,肠道菌群的失调 (微生物群失调) 与脂肪肝疾病的发展有关.
- 虽然遗传因素会导致个体的倾向性,但高果糖,动物产品和和脂肪的饮食模式显著改变了肠道微生物群,促进了肝脏肥胖症.
研究的目的:
- 审查当前对肠道微生物群在肝硬化病原发生中的作用的理解.
- 探索肠道细菌如何影响营养代谢,炎症和脂肪在肝脏中的积累.
- 为了确定肠道微生物群中的潜在治疗点,用于管理脂肪肝疾病.
主要方法:
- 文献综述综合了关于肠道微生物群和肝脏肥胖症的当前研究.
- 分析了将饮食习惯与微生物组合和肝脏健康联系起来的研究.
- 检查肠道细菌影响肝脏脂肪沉积和炎症的机制.
主要成果:
- 由饮食驱动的肠道微生物组失调是肝硬化发病率上升的一个重要因素.
- 特定的肠道细菌及其代谢活动可以促进炎症途径和脂肪在肝脏中的积累.
- 遗传因素有助于易感性,但并不能完全解释脂肪肝疾病的患病率增加.
结论:
- 肠道微生物群是肝硬化症发展的关键调节者.
- 针对肠道微生物群的饮食干预措施为预防和治疗脂肪肝疾病提供了有希望的途径.
- 调节肠道微生物群代表了肝硬化和相关代谢障碍的潜在治疗策略.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
952
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
1.2K
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
697
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
697
01:17Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
01:26Diseases of the Liver and Gallbladder
622
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
622
01:17Gastritis-II: Pathophysiology
371
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
371
01:24Overview of Lipid Metabolism
1.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.7K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213